| 57 | A MULTICENTER PROSPECTIVE PHASE II RANDOMIZED TRIAL OF EPIRUBICIN/VINORELBINE VERSUS PEGYLATED LIPOSOMAL DOXORUBICIN/VINORELBINE AS FIRST-LINE TREATMENT IN ADVANCED BREAST CANCER. A GOIM STUDY | P. Vici, G. Colucci, F. Giotta, D. Sergi, G. Filippelli, P. Perri, C. Botti, E. Vizza, A. Carpino, L. Pizzuti, A. Latorre, D. Giannarelli, M. Lopez, L. Di Lauro: | Journal of J Experimental & Clinical Cancer Research 2011; 30-39 | 2.148 | 4.429 |
| 58 | CISPLATIN, FOTEMUSTINE AND WHOLE-BRAIN RADIOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ASYMPTOMATIC BRAIN METASTASES: A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO ITALIA MERIDIONALE (GOIM 2603) | D. Galetta, V. Gebbia, N. Silvestris, F. Ferra?, F. Carrozza, S. Cigolari, P. Russo, F. Calista, V. Adamo, G. Colucci: | Lung Cancer 2011; 72: 59-63 | 3.434 | 3.958 |
| 59 | INDUCTION PEMETREXED AND CISPLATIN FOLLOWED BY MAINTENANCE PEMETREXED VERSUS CARBOPLATIN PLUS PACLITAXEL PLUS BEVACIZUMAB FOLLOWED BY MAINTENANCE BEVACIZUMAB: A QUALITY OF LIFE-ORIENTED RANDOMIZED PHASE III STUDY IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON | Galetta D, Pisconti S, Cinieri S, Pappagallo GL, Gebbia V, Borsellino N, Maiello E, Rinaldi A, Montrone M, Rizzo P, Marzano N, Sasso N, Febbraro A, Colucci G.: | Clin Lung Cancer. 2011, Vol. 12, No. 6, 402-6 | 2.944 | 3.104 |
